FDA Approved: POSACONAZOLE — Supplemental Application (Mylan Institutional LLC)

View source ↗

Summary

FDA approved a supplemental application for posaconazole from Mylan Institutional LLC, updating the approval for the generic product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Candidiasis
• Cryptococcosis
• Invasive Aspergillosis
• Invasive Fungal Infections
• Mucormycosis
• Oropharyngeal Candidiasis

Drugs mentioned

• POSACONAZOLE (POSACONAZOLE)

Snippet

SUPPL AP for POSACONAZOLE (POSACONAZOLE)